JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dibona, G. F.
Right arrow Articles by Sawin, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dibona, G. F.
Right arrow Articles by Sawin, L. L.

Renal tubular site of action of felodipine

GF Dibona and LL Sawin

The renal tubular site of action of felodipine was localized using renal clearance and recollection micropuncture techniques in the anesthetized rat. In initial renal clearance experiments, felodipine (2.75 nM/kg/min i.v. X 60 min) had no effect on mean arterial pressure or glomerular filtration but significantly increased urinary flow rate, sodium and potassium excretion. In subsequent recollection micropuncture experiments, felodipine decreased mean arterial pressure but did not affect renal blood flow or renal vascular resistance or glomerular filtration rate; absolute and fractional urinary excretion of sodium and water, but not potassium, were increased. Proximal tubular and loop of Henle sodium, potassium and water reabsorption were not affected but distal tubular and collecting duct sodium and water (not potassium) reabsorption were decreased by felodipine. Felodipine is a vasodilator antihypertensive agent which, in doses which decrease mean arterial pressure in normotensive rats, increases urinary flow rate and sodium excretion by inhibiting distal tubular and collecting duct sodium and water reabsorption; potassium reabsorption or excretion is not affected. As a vasodilator antihypertensive agent, felodipine possesses beneficial natriuretic rather than detrimental sodium retaining properties.

Volume 228, Issue 2, pp. 420-424, 02/01/1984
Copyright © 1984 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. Nishiyama, K. E. Jackson, D. S. A. Majid, M. Rahman, and L. G. Navar
Renal interstitial fluid ATP responses to arterial pressure and tubuloglomerular feedback activation during calcium channel blockade
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H772 - H777.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. S. Segal, J. P. Hayslett, and G. V. Desir
On the natriuretic effect of verapamil: inhibition of ENaC and transepithelial sodium transport
Am J Physiol Renal Physiol, October 1, 2002; 283(4): F765 - F770.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. Yamasaki, M. Ohmagari, I. Tamai, K. Hayashi, and Y. Matsumura
Inhibitory Effects of AE0047, a New Dihydropyridine Ca2+ Channel Blocker, on Renal Nerve Stimulation-Induced Renal Actions in Anesthetized Dogs
J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 1040 - 1047.
[Abstract] [Full Text]

Home page
 HypertensionHome page
L.-T. Dijkhorst-Oei, T. J. Rabelink, P. Boer, and H. A. Koomans
Nifedipine Attenuates Systemic and Renal Vasoconstriction During Nitric Oxide Inhibition in Humans
Hypertension, May 1, 1997; 29(5): 1192 - 1198.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1984 by the American Society for Pharmacology and Experimental Therapeutics.